Increased serum malondialdehyde levels are associated with grey matter volume loss in patients with non-alcoholic cirrhosis.
Background
Grey matter volume (GMV) loss has been observed in patients with non-alcoholic cirrhosis, but the underlying mechanisms are unknown. Oxidative stress (OS) is a recognized feature and systemic phenomenon of cirrhosis. However, little is known about whether OS is associated with GMV loss in cirrhosis. This study aimed to assess the relationship between oxidative damage and GMV loss in patients with non-alcoholic cirrhosis.


Methods
Thirty-four patients with non-alcoholic cirrhosis and 27 age- and sex-matched healthy controls were enrolled in this prospective study. All subjects underwent brain magnetic resonance imaging (MRI), and voxel-based morphometry (VBM) was performed to assess normalized global GMV. As an OS marker, serum malondialdehyde (MDA) levels were determined in all subjects. In the patient group, a correlation analysis was used to investigate the relationship between serum MDA levels and normalized global GMV.


Results
Compared with healthy controls, cirrhotic patients displayed a significant decrease in normalized global GMV and a significant increase in serum MDA levels. In the patient group, serum MDA levels were negatively correlated with normalized global GMV adjusted for age, sex and Child-Pugh class.


Conclusions
Increased serum MDA levels were associated with GMV loss in patients with non-alcoholic cirrhosis, suggesting that oxidative damage may be involved in GMV loss observed in cirrhotic patients.
['Zheng|Wei|W|', 'Zhu|Wen-Wei|WW|', 'Feng|Zhi-Chao|ZC|', 'Liang|Qi|Q|', 'Rong|Peng-Fei|PF|', 'Li|Li-Feng|LF|', 'Liao|Yun-Jie|YJ|', 'Wang|Wei|W|']
malondialdehyde Cirrhosis grey matter volume (GMV) oxidative stress